New heart failure drug trial aims to cut hospital stays and save lives
NCT ID NCT07444398
First seen Mar 14, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study tests whether adding the drug vericiguat to standard heart failure treatments helps people with worsening heart failure. About 130 adults with severe symptoms and low heart function will receive either vericiguat or a placebo. Researchers will track hospitalizations, heart-related deaths, and side effects over 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Armed Forces Institute of Cardiology. Pakistan
RECRUITINGRawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.